Takeda Oncology

“Introducing New Therapeutic Innovation for Hodgkin Lymphoma Cancer”

The Challenge

When people think about one of the deadliest diseases in the world, cancer undoubtedly would be one of them. WHO reported that cancer is the second leading cause of death globally and was responsible for 8.8 million deaths in 2015.

Being one of the world’s leading pharmaceutical companies, Takeda Oncology is determined to build awareness and understanding of cancer, particularly Hodgkin Lymphoma while at the same time introducing a new innovation.

Our Approach

ID COMM was appointed to arrange a media discussion with responsibilities of strategic media angle and content development, media relations and event arrangement.

The Result

As a result, Takeda Oncology succeed to secure coverage from top tier publication. In total, the event generated 72 news coverage, almost 70 percent of it came from first and second tier media. The event was also covered not just by health publications, but also general publication such as Kompas, Tempo and Koran Sindo.